In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds.
The two available drugs for treatment of T. cruzi infection, nifurtimox and benznidazole (BZ), have potential toxic side effects and variable efficacy, contributing to their low rate of use. With scant economic resources available for antiparasitic drug discovery and development, inexpensive, high-t...
Saved in:
Main Authors: | Adriana M C Canavaci (Author), Juan M Bustamante (Author), Angel M Padilla (Author), Cecilia M Perez Brandan (Author), Laura J Simpson (Author), Dan Xu (Author), Courtney L Boehlke (Author), Rick L Tarleton (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2010-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection.
by: Gretchen Cooley, et al.
Published: (2008) -
Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge.
by: Cecilia Perez Brandan, et al.
Published: (2011) -
THE ROLE OF IMMUNOLOGY IN COMBATING TRYPANOSOMA CRUZI INFECTION AND CHAGAS DISEASE
by: Rick L. Tarleton
Published: (2013) -
High throughput screening for anti-Trypanosoma cruzi drug discovery.
by: Julio Alonso-Padilla, et al.
Published: (2014) -
Activity in vivo of anti-Trypanosoma cruzi compounds selected from a high throughput screening.
by: Grasiella Andriani, et al.
Published: (2011)